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Abstract: In the anuran family Dendrobatidae, aposematic species obtain their toxic or unpalatable
alkaloids from dietary sources, a process known as sequestering. To understand how toxicity
evolved in this family, it is paramount to elucidate the pathways of alkaloid processing (absorption,
metabolism, and sequestering). Here, we used an exploratory skin gene expression experiment in
which captive-bred dendrobatids were fed alkaloids. Most of these experiments were performed with
Dendrobates tinctorius, but some trials were performed with D. auratus, D. leucomelas and Allobates
femoralis to explore whether other dendrobatids would show similar patterns of gene expression.
We found a consistent pattern of up-regulation of genes related to muscle and mitochondrial processes,
probably due to the lack of mutations related to alkaloid resistance in these species. Considering
conserved pathways of drug metabolism in vertebrates, we hypothesize alkaloid degradation is a
physiological mechanism of resistance, which was evidenced by a strong upregulation of the immune
system in D. tinctorius, and of complement C2 across the four species sampled. Probably related
to this strong immune response, we found several skin keratins downregulated, which might be
linked to a reduction of the cornified layer of the epidermis. Although not conclusive, our results
offer candidate genes and testable hypotheses to elucidate alkaloid processing in poison frogs.
Keywords: Dendrobatidae; Aromobatidae; Dendrobates; Allobates; epibatidine; gene expression;
feeding experiment; immune system; resistance
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1. Introduction
Alkaloids are unpalatable or toxic substances, and have been documented in five families of
anurans [1–5]. In one of these families, Dendrobatidae, the ability to uptake and store alkaloids
from the diet, known as sequestering, evolved independently at least four times [6–8]. In this family,
sequestering has been shown as the main predictor of aposematism [8,9], which is the association
of unprofitability with a warning signal to predators, usually a conspicuous coloration. However,
aposematism in dendrobatids is considered a complex phenotype because it has been associated
with many other traits, such as diet specialization, high active metabolic rate, high rate of molecular
evolution and speciation, high calling rates at lower frequencies, conspicuous behavior, and larger
body mass and body size [6,8,10–18]. Hence, to understand the complex evolution of aposematism in
this family, it is paramount to investigate the molecular basis of alkaloid processing.
The processing of alkaloids in dendrobatids includes their absorption, metabolism and
sequestering. Alkaloid absorption might occur along the digestive system through simple diffusion,
given their lipophilic nature [19] or through ABC transporter proteins [20]. Once absorbed, alkaloids
might either circulate freely, as part of lipoproteins, or bind to carrier protein(s). However, before
they reach the tissue of storage, they could (or not) be metabolized. For example, they could be
biotransformed by cytochrome P450 enzymes (hereafter CYPs) in the liver [20], which have been
found differentially expressed in a study comparing wild and captive Oophaga sylvatica [21]. However,
from a biochemical point of view, alkaloid processing in poison frogs is remarkable because they are
sequestered without modifying their molecular structure in most cases [5]. The binding of alkaloids to
carrier protein(s) might protect them from biotransformation, and recently a potential carrier protein,
saxiphilin, has been identified in a dendrobatid [21]. Finally, either freely or bound to a carrier, alkaloids
should be internalized by storage tissues. Although alkaloids have been found in several tissues
of poison frogs [22], they are mainly stored in the skin, purportedly in the granules of the granular
glands [23–25]; hence, the skin is a target organ in which to study alkaloid internalization and storage.
An important part of alkaloid processing is resistance to autotoxicity. The best-studied mechanism
of resistance in poison frogs is the accumulation of mutations in target ion-channels or receptors [9,26–31].
For instance, the poison frog alkaloid epibatidine [32], which we used in the present study, acts by
binding to nicotinic acetylcholine receptors [33]. During the evolution of dendrobatids, nucleotide
substitutions in the binding site for this receptor have been selected, which confer resistance yet
leave the receptor’s function virtually unchanged [9]. However, resistance to alkaloids might also
be achieved through other mechanisms. Storage of alkaloids could be considered a mechanism of
resistance [34] because it involves compartmentalization, i.e., the storage of most of the alkaloids in a
reduced number of organelles, cells or tissues, which limits their interaction with target tissues such
as the muscles [35]. The mechanisms behind receptor modification and alkaloid storage might have
evolved through selection in lineages recurrently exposed to alkaloids [32,36], possibly through diet
specialization [6,7,11,37,38]. Other mechanisms to deal with autotoxicity might involve the metabolism
of dietary alkaloids [34]. For example, in vertebrates, the biotransformation of small molecules usually
makes them more hydrophilic, making it easier to excrete them through urine and/or allowing the
binding of other molecules for their degradation [19].
In this study, we performed a series of feeding experiments coupled with gene expression analyses
on skin samples from captive-bred poison frogs to gain insights into the molecular responses of
poison frogs to alkaloids. Our working hypothesis was that alkaloid processing pathways would be
differentially expressed in frogs with control and alkaloid diets. More specifically, we predicted that,
in captive-bred alkaloid-free frogs, any alkaloid-related pathways would be expressed in basal amounts,
whereas these same pathways would be overexpressed in captive-bred frogs fed with alkaloids for the
first time. Furthermore, we expected that their expression over time would be regulated due to the
half-life of the proteins involved in these pathways. We further hypothesized that some components of
the alkaloid processing pathways are conserved among dendrobatids and, hence, different species
would present similar gene expression patterns upon alkaloid consumption.
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Glossary
Alkaloid absorption Up-take of alkaloids from dietary items.
Biotransformation Structural change of a compound. For example, the conversion of pumiliotoxin
(+)-251D into allopumiliotoxin (+)-267A known from Dendrobates and
Adelphobates [39].
Alkaloid degradation Breakdown of alkaloids or alkaloid derivatives.
Alkaloid metabolism Biotransformation, excretion or degradation of alkaloids.
Bioaccumulation Accumulation of alkaloids because they are not metabolized at the same rate in
which they are absorbed.
Alkaloid sequestering Ability to absorb alkaloids, and internalize and store them in selected tissues or
cells.
Alkaloid resistance Avoidance of alkaloid toxicity. It can be achieved through several mechanisms,
including mutations in target ion-channels and receptors, sequestering or
metabolism.
Alkaloid processing Absorption, metabolism and sequestering of alkaloids.
2. Methods
2.1. Poison Frogs
We performed alkaloid feeding experiments on captive-bred poison frogs of the family
Dendrobatidae (here defined as containing Dendrobatinae and Aromobatinae; see discussion
in [36,40–42]. Nine Dendrobates tinctorius and four D. auratus were obtained from Understory
Enterprises (Charing Cross, Ontario, Canada) and DendroWorld (Bullecourt, France), two D. leucomelas
and two Epipedobates anthonyi were obtained from Terraristik Braunschweig (Brunswick, Lower
Saxony, Germany), and three Allobates femoralis were obtained from the frog colony at the University
Vienna, Austria. Frogs were full-siblings specifically bred for our experiments (see Table SM2.1 for
detailed information on the experimental subjects). Frogs were kept in independent plastic containers
(17.5x11x12 cm) under similar conditions of light and temperature during the experiments. All the
animals sampled were at least one year old prior to the commencement of experiments. Permission
to house poison frogs was issued by the Veterinäramt Stadt Braunschweig in Germany, and feeding
experiments were ethically approved by the Niedersächsisches Landesamt für Verbraucherschutz
und Lebensmittelsicherheit (No. 33.19-42502-04-15/1900) in Germany. Additionally, we sampled two
wild-caught D. leucomelas in Guri, Bolívar State, Venezuela (8◦18’51”N, 62◦39’56”W), under collection
permits issued by Oficina Nacional de Diversidad Biológica (No. 0908 and No. 0217) in Venezuela.
2.2. Experimental Design for Gene Expression
Three different experimental treatments were applied: (i) control, in which frogs were maintained
on an alkaloid-free diet for eight days, (ii) single-dose treatment, in which frogs were on an alkaloid-free
diet, but fed with alkaloids on the seventh day, and (iii) multi-dose treatment, in which frogs received
an alkaloid diet throughout the eight days of the experiment (Figure 1A, Table SM2.1). The same
amount of food was offered to each animal, 8-12 fruit-flies (Drosophila sp.) per day. Flies were dusted
with either vitamin powder (Nekton-Rep, NEKTON GmbH, Germany) in the control, or with a mixture
of vitamin powder and alkaloids for the single-dose and multi-dose treatments. We administered
three different alkaloid composition treatments: epibatidine only (2% m/m), sparteine only (2% m/m),
or a mixture of epibatidine, sparteine, berberine, lupinine and quinine (1% m/m each) (Figure 1A,
Table SM2.1). Although we tried to control the quantity of alkaloid given to each frog by offering
the same number of fruit-flies and having a mixture with a known concentration of alkaloid, it is
impossible to know how much alkaloids were consumed by each frog. Epibatidine was used because
it is the only poison frog alkaloid commercially available, although it has naturally been found only
in Epipedobates and Ameerega spp. [32]. Because epibatidine is a highly toxic alkaloid (LD50 ~0.2
mg/kg; [43]), and A. femoralis is considered a non-toxic dendrobatid species ([44], but see [45] and [46]),
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we judged using the less toxic alkaloid sparteine (LD50 ~200 mg/kg; [47]) for this species. Sparteine is
an alkaloid from plants of the genus Lupinus, which has a similar structure to epibatidine but belongs
to the quinolizidine class (Figure 1B).
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Epipedobates spp., and sparteine, which occurs naturally in plants Lupinus spp. C Individuals fed
long-term with alkaloids to confirm whether they sequester these alkaloids using GC/MS.
2.3. RNA-Seq, Transcriptome Assemblies and Annotation
We used whole skin samples because initially we wanted to focus on sequestering, especially
alkaloid int rnalization and storage by th sk n. Thes samples were take 10 minutes aft r the last
feeding, a d stored in RNA-later at -80◦C. RNA was extracted using a TRIzol protocol and prepared
or sequencing with the Illumina TruSeq Stranded mRNA Libra y Prep protocol (San Diego, CA, USA).
Sequencing was carried out on Illumina NextSeq sequencer (Max Planck Institute for Evolutionary
Biology, Plön, Germany) using NextSeq V 500/550 High Output Kit v2 (2 × 75 bp paired-e d; San
Diego, CA, USA). Sequences were quality-trimmed with Trimmomatic 0.32 (slidingwindow:4:10
le ding:5 trailing:5 minlen:50; [48]) and normalized with BBnorm (target = 40 mindepth = 2; https:
//jgi.doe.gov/data-and-tools/bbtoo s/). The transcriptome of each species was de-novo assembled
from the quality-trimmed reads of each sample using Trinity 2.1.1 (–m n_k r_cov 2 –SS_l b_type
RF; [49]). W used DRAP [50] with default param ter t maximize compact ess wh le reducing
ch merism and assembly errors in the transcriptomes. Only transcripts with FPKM > 1 (Frag ents Per
Kilob se of transcript per Million mapped reads) were kept for fur her analyses. The quality of the
transcriptomes was evaluated with TransRate [51] and BUSCO v3 [52]. Tr nscriptome were annotated
using Annocript [53] with he default configuration, with the SwissProt and UniRef90 s reference
databases (Ma ch 2017; [54]). For e ch sample, reads were mapped to the corresponding spec es
ranscr ptome using Bowtie [55], and abund nces per transcript were estim ted with RSEM [56] as
implemented in the Trinity protocol [49].
2.4. Gene Expression in Dendrobates Tinctorius
The D. tinctorius dataset was represented by a minimum of replicates per treatment (control n = 3,
single-dose n = 2, multi-dose n = 3; Figure 1A), and was used to identify gene expression patterns
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associated with alkaloid processing pathways. This dataset was analyzed at the transcript level as there
is no gene-transcript map available for the species and we did not want to exclude new yet unannotated
genes from the analysis. Abundances were first normalized by library size with edgeR [57] using TMM
(Trimmed Mean of M-values). Using this matrix, we built a multidimensional scaling plot with edgeR
function plotMDS, and performed an analysis of similarities (ANOSIM) between treatments using the
package vegan [58]. Differential expression analyses were performed in edgeR for the comparisons
single-dose vs control, multi-dose vs control, single-dose vs multi-dose, and alkaloid (i.e., single-dose
and multi-dose together) vs control, with the cut-offs false discovery rate (FDR) < 0.05 and absolute
log-fold change (logFC) > 2. Based on the transcript annotation, genes that contained both up- and
down-regulated transcripts were not used for downstream analyses.
To test if the differentially expressed genes were functionally connected (i.e., not random),
we generated interaction networks using the STRING database [59], as implemented in the StringApp
plug-in for Cytoscape 3.7.0 [60]. For this, we used the best blast hits of D. tinctorius predicted proteins
on the human proteome. Briefly, StringApp builds a network of the input genes, and compares its
connectivity (number of interactions) to the connectivity of other networks of similar size generated
with random sets of genes.
To test whether Gene Ontology (GO) terms were enriched in the differentially expressed transcripts,
enrichment analyses were conducted with the StringApp using the human GO dataset as a reference
and a cutoff value of FDR < 0.05.
2.5. Multi-Species Comparison
The multi-species dataset contained data of experimentally fed D. tinctorius, D. leucomelas,
D. auratus, and A. femoralis, and wild D. leucomelas (Figure 1A). For the transcriptome of each species,
we generated a SwissProt annotation – transcript mapping file that was used to summarize the estimated
abundances by gene (SwissProt annotation) with the R package tximport [61]. These abundances were
further normalized across species by library size using TMM in edgeR. This matrix was used to calculate
logFC between treatment-control pairs using the R package gtools. It contained 11 treatment-control
pairs, including single-dose, multi-dose and wild individuals versus their controls. Controls were
control individuals of the same full-sibling group (see SM1), or, in the case of wild D. leucomelas,
the control was the control captive-bred individual.
Multi-species data were explored using two different approaches. First, we specifically examined
the genes found to be differentially expressed in the D. tinctorius comparisons single-dose vs control,
multi-dose vs control, and alkaloid vs control. Second, we searched for genes with similar strong
expression patterns (logFC > 2 or logFC <-2) in at least 6 out of 11 treatment-control pairs. The expression
patterns of these genes were visualized across species using heatmaps.
Alignments of transcript sequences with positive blast hits on the nicotinic acetylcholine receptor
ß2 (CHRNB2) were used to explore whether the species used in this study have mutations conferring
resistance, according to [9] because it has not been previously reported for the Dendrobates species here
included. CHRNB2 is one of the main targets of epibatidine [33], which was the alkaloid we used for
feeding experiments in D. tinctorius, D. leucomelas, and D. auratus.
2.6. Alkaloid Sequestering Confirmation Tests
To test whether the two supplied alkaloids, epibatidine and sparteine, were effectively sequestered
by poison frogs, we conducted long-term (min. 1 month) feeding experiments on a different set
of frogs (Figure 1C). Captive bred frogs were fed with fruit flies dusted with a mixture of vitamin
powder and alkaloid at 2% m/m. For E. anthonyi, one individual was fed with alkaloid-free flies as a
control and another individual was fed with epibatidine dusted flies; for D. tinctorius, one individual
was fed with epibatidine; for D. auratus, one individual was fed with a mixture of sparteine and
epibatidine; and for A. femoralis, one individual was fed with sparteine (Figure 1C; SM2). One wild
D. leucomelas was used for comparative alkaloid profiling (i.e., as natural positive reference). Frogs
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were rinsed with milli-Q water to avoid external contamination, and whole skin samples were taken
and placed in approximately 400 µL dichloromethane. Samples were stored at −20◦C until processing.
For gas chromatography-mass spectrometry (GC / MS) analysis, 1 µL of the extract was injected into an
Agilent 7890A GC system (Technische Universität Braunschweig, Braunschweig, Germany) containing
a HP-5MS-fused silica capillary column (30 m, 0.25 mm i.d., 0.25 µm flm) with an Agilent 5975C inert
mass detector. Analyses were carried out using an inlet pressure of 77.1 kPa with helium flow of 1.3 ml
/min. The transfer line was heated to 300◦C and the electron energy set to 70 eV. GC program was as
follows: 5 min at 50◦C, and then a temperature gradient of 10◦C per minute until 320◦C. Injections
were performed in split-less mode with 60 s valve time.
3. Results
3.1. Transcriptomes
The assembled transcriptomes of dendrobatids (SM2) contained between 50 and 85 thousand
transcripts each, had a Transrate assembly score of 0.15-0.21, and recovered about 76-89% of the BUSCO
ortholog groups for vertebrates. Between 36 and 49% of the transcripts of each transcriptome were
annotated to the SwissProt or UniRef90 databases.
3.2. Gene Expression of D. Tinctorius
In D. tinctorius, gene expression differed among treatments (ANOSIM R=0.4, p = 0.029). In the
MDS plot (Figure 2A), samples clustered by treatment, in which multi-dose individuals were closer
to the control ones than the single-dose individuals (x-axis). There was also a separation between
individuals that consumed only epibatidine, and those that consumed the alkaloid mixture (y-axis),
although this factor is confounded with the genetic full-sibling groups (SM2).
For the single-dose vs control comparison, 313 transcripts were differentially expressed (186 down-
and 127 up-regulated). Following their SwissProt annotation, these transcripts correspond to 141 genes
(81 up- and 60 down-regulated; Table SM3.1). The number of interactions among differentially
expressed genes was significantly higher than expected from random sets of genes (p-value = 1.0e-16;
Figure SM4.1). Non-redundant enriched biological process GO-terms (Figure 2C) included innate
immune response (GO:00045087, FDR = 0.045), adaptive immune response (GO:0002250, FDR = 0.023),
muscle system process (GO:0003012, FDR = 0.049), cornification (GO:0070268, FDR = 0.009), aerobic
electron transport chain (GO:0019646, FDR = 0.049; hereafter respiration) and epoxygenase P450
pathway (GO:0019373, FDR = 0.037; all CYPs).
For the multi-dose vs control comparison, 112 transcripts were differentially expressed (49 down-
and 63 up-regulated). These were annotated to 63 genes (37 up- and 26 down-regulated; Table SM3.2).
The number of interactions among these genes was significantly higher than for random sets of
genes (p-value = 1.35e-6; Figure SM4.2). Non-redundant enriched biological process GO-terms
(Figure 2D) included immune response (GO:0006955, FDR = 0.030), muscle filament sliding (GO:0030049,
FDR = 0.030) and lipid hydroxylation (GO:0002933, FDR = 0.030; all CYPs).
For the single-dose vs multi-dose comparison, 42 transcripts were differentially expressed
(16 over-expressed in the single-dose and 26 in the multi-dose), corresponding to 27 genes
(11 over-expressed in the single-dose and 16 in the multi-dose; Table SM3.3). The number of
interactions among these genes was not significant when compared to a random set (p-value = 0.259;
Figure SM4.3), and biological process GO-terms were not enriched. It is, however, worth mentioning
that the mitochondrial gene for CO1, previously related to the GO-term aerobic electron transport
chain, was over-expressed in single-dose when compared to the multi-dose treatment.
For the alkaloid vs control comparisons, 24 transcripts were differentially expressed (17 up- and
7 down-regulated), corresponding to 15 genes (13 up- and 2-regulated; Table SM3.4). The number
of interactions among these genes was significant when compared to a random set (p-value = 0.0002;
Figure SM4.4). Most up-regulated genes were related to the GO-terms (Figure 2E) immune response
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(GO:0006955, FDR = 6.06e-05), and the two down-regulated genes were keratins related to the GO-term
cornification (GO:0070268, FDR = 0.0351).
There was an overlap of 24 genes (17 up- and 7 down-regulated) identified in the single-dose vs
control, and multi-dose vs control comparisons (Figure 2B). Of these genes, 9 overlapped with the
alkaloid vs control comparison (8 up- and 1 down-regulated; Figure 2B). Up-regulated genes were
related to immune response, and the downregulated gene was a keratin.
See SM2 for all GO-enrichment results, including Cellular Component and Molecular Function.
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Figure 2. Gene expression of D. tinctorius upon a single dose or multiple doses of alkaloids. A. MDS
plot showing the expression distances between samples coded by treatment. Distances were calculated
from the logFC of the 500 transcripts with the highest standard deviations between conditions. Closed
symbols = epibatidine. Open symbols = alkaloid mixture. B. Venn diagram showing the number of
differentially expressed genes found for the three comparisons single-dose vs. control, multi-dose
vs. control, and alkaloid (i.e., single-dose and multi-dose) vs. control. Numbers in red indicate
over-expression in the alkaloid treatment, and numbers in blue indicate over-expression in the control.
C. Enriched biological process GO-terms for the single-dose vs control comparison D. Enriched
biological process GO-terms for the multi-dose vs. control comparison. E. Enriched biological process
GO-terms for the alkaloid vs. control comparison.
3.3. Multi-Species Comparison
The final multi-species dataset contained 3839 genes, including 62 of the genes identified as
differentially expressed in the single-dose vs control and multi-dose vs control comparisons for
D. tinctorius (Fig re SM6.1, and Table SM5.1). After filtering by logFC > ±2 in 6/11 treatment pairs,
we ide tified 27 genes with similar patterns of expression across species (Figure SM6.2, Table SM5.2).
Some of the genes identified using both approaches could be roughly related to muscle process,
mitochondria, CYPs, immune response, and cornification, according to their associated biological
process GO-terms (Figure 3).
When comparing the sequences of CHRNB2 of these poison frogs, none of the species tested had
the known mutations conferring resistance to epibatidine (Table SM2), in agreement with previous
data on other species of the same major dendrobatid clades [9].
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pumiliotoxin class. 
4. Discussion
Here, we will discuss our results in the context of conserved pathways for alkaloid processing 
in dendrobatids, considering the limitations of our experimental design. Although initially 
conceived as a study on alkaloid sequestering by the skin, our interpretations of the data are 
hindered because we could not validate the sequestration of epibatidine in our main study species, 
D. tinctorius. Furthermore, our results may to a large degree reflect an early physiological response
by the frogs, because we used samples taken shortly after alkaloid (or control) consumption. We
would also like to point out that the small sample size and use of alkaloids that do not occur
naturally in the species included in our study might limit some of our conclusions, and hence our
Figure 3. LogFC of genes of interest found across species. Species on the top: TINC = D. tinctorius,
AURA = D. auratus, LEUC = D. leucomelas, AFEM = A. femoralis. Treatments on the bottom:
SE = single-dose epibatidine, SA = single dose alkaloid mixtures, ME = multi-dose epibatidine,
MA = multi-dose alkaloid mixture, MS = multi-dose sparteine, W = wild. On the left, we indicated,
with a box filled black, the approaches used to identify each gene. Approaches: F = filtering by
expression pattern, S = single-dose vs control results for D. tinctorius, M = multi-dose vs control results
for D. tinctorius, A = alkaloid (i.e., single-dose and multi-dose) vs control results for D. tinctorius. On
the right, genes have been grouped according to their broad biological significance. For visualization,
this heatmap has a ceiling of logFC ± 2. LogFC values are given in SM5.
3.4. Alkaloid Sequestering
GC/MS of skin extracts (SM7) indicate that E. anthonyi fed a control diet do not have alkaloids,
but sequester dietary provided epibat dine, supporting a di tary rigin of epibatidine in naturally
occurring members of this species; D. auratus sequestere both epibatidin and sparteine, but its
congener D. tincto ius did not sequester epibatidine; A. femoralis was unexpectedly able to sequester
sparteine; wild-caught D. leucomelas conta ned many different alk loids, most of which were of the
pumil otoxin class.
4. Discussion
Here, we will discuss our results in the context of conserved pathways for alkaloid processing in
dendrobatids, considering the limitations of our experimental design. Although initially conceived as
a study on alkaloid sequestering by the skin, our interpretations of the data are hindered because we
could not validate the sequestration of epibatidine in our main study species, D. tinctorius. Furthermore,
our results may to a large degree reflect an early physiological response by the frogs, because we
used samples taken shortly after alkaloid (or control) consumption. We would also like to point out
that the small sample size and use of alkaloids that do not occur naturally in the species included in
our study might limit some of our conclusions, and hence our results and interpretations should be
rather taken as testable hypotheses. Despite these partial deviations from our initial goals, our results
allowed for some preliminary, yet novel insights into transcriptomic responses of poison frogs upon
alkaloid uptake.
4.1. Gene Expression Patterns
In D. tinctorius, more genes were differentially expressed after the first-dose of alkaloids
(single-dose treatment) than after eight days of sustained alkaloid consumption (multi-dose treatment),
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when compared to the controls. Both comparisons had considerable overlap in up- and down-regulated
genes, and therefore we only found a few genes differentially expressed between these treatments
(single-dose vs multi-dose comparison). These results are consistent with our initial hypothesis that
the expression of genes related to alkaloid processing would be regulated after continued alkaloid
consumption. Most genes differentially expressed in these two comparisons code for proteins that
interact with each other, and we could identify enriched biological process GO-terms broadly related
to muscle processes, CYPs, immune response, mitochondria, and cornification. Two of these GO-terms,
immune response and cornification, were enriched when pooling together single-dose and multi-dose
(i.e., alkaloid treatments) and comparing to the controls. The results of this last comparison might be
more reliable because it has a higher sample size (alkaloid N = 5 vs control N = 3); however, it would be
necessary to carry out more studies to confirm these are processes differentially regulated by naturally
occurring alkaloids as well.
Across the species sampled in our study, we observed some concordances in gene expression
patterns with the results found in D. tinctorius, including species that experimentally sequestered
alkaloids (D. auratus, A. femoralis) and in our wild-caught frogs (D. leucomelas). This suggests that
some general mechanisms of alkaloid processing might exist across dendrobatids. Concordant genes
were included in enriched processes identified in D. tinctorius, such as muscle processes, immune
response, mitochondria, and cornification, suggesting that these biological processes are relevant to
early response (immediately and after 8 days) of poison frogs to alkaloid consumption.
4.2. Potential Biological Significance
The species sampled in our study did not have mutations known to confer resistance. Although
we did not observe outward signs of intoxication in individuals that were fed for over a month on
an epibatidine diet, there was an upregulation of genes related to muscle processes, and epibatidine
is known to cause muscle contraction [35]. Poison frog alkaloids, in general, are also known to
increase or decrease respiration rate in vertebrates [62]), and here we observed an upregulation of
mitochondrial genes. Together, the upregulation of muscle and mitochondrial processes may indicate
that epibatidine-fed frogs were impacted by the effects of this alkaloid. Furthermore, upregulation of
mitochondrial processes in frogs that consume alkaloids might be linked to the higher active metabolic
rate of dendrobatid species that sequester alkaloids [8], and support that alkaloid processing is
energetically costly. Future research might address how alkaloid consumption influences the metabolic
rate of poison frogs.
D. tinctorius did not sequester epibatidine, but also did not die from consuming this highly toxic
alkaloid, which might imply that resistance was achieved through a mechanism other than target-site
mutations or sequestering. We interpret the up-regulation of CYPs and immune response as an
indication that fast alkaloid degradation could be a mechanism of resistance. In vertebrates, drug or
toxin degradation usually begins with their biotransformation by CYPs in the liver. However, other
tissues such as the skin also express CYPs and thus might be involved in the biotransformation of
toxins as well [63]. One of the up-regulated CYPs in single-dosed D. tinctorius was an ortholog of
the human CYP3A4, which is responsible for biotransforming over half of all drugs used in human
medication [64].
Different parts of the innate and adaptive immune systems were upregulated in epibatidine fed
D. tinctorius. To be recognized by cells of the immune system in the plasma, small molecules should
bind to carrier proteins, which is facilitated by their biotransformation [19]. Although speculative,
the up-regulation of several genes related to the adaptive immune system in D. tinctorius could suggest
that alkaloids act as haptens, which allows for an alkaloid-carrier complex to be recognized as an
antigen by immune system cells [65]. Supporting this, several genes related to adaptive immune system
were upregulated in D. tinctorius, e.g. immunoglobulins. In this scenario, the adaptive immune system
would activate the innate complement system, here evidenced, for example, by the upregulation of the
complement protein C2 across the four species sampled. Finally, the alkaloid-carrier complex would
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be phagocytized and degraded by cells of the immune system [19], which could partly explain why
epibatidine was not identified in the skin of D. tinctorius. Although the interaction of alkaloids through
these pathways remains to be confirmed, this is not the first study to find a link between alkaloid
processing and immune system. A recent study on O. sylvatica showed that the immune system protein
complement C3 was up-regulated in plasma in wild individuals when compared to captive frogs [21].
Hence, alkaloid degradation or changes to the immune system might be especially important for the
evolution of toxicity in dendrobatids (and possibly other poison frogs) as these pathways are conserved
in vertebrates to avoid intoxication and fight infections [66–68]. Additional research will be needed to
examine how the immune system is involved in alkaloid processing.
Across the four species sampled herein, we found a downregulation of keratins. Interestingly,
one of the keratins found down-regulated in D. tinctorius, KRT24, was also found down-regulated
in the skin of wild O. sylvatica [21]. This might result from the apoptosis of keratinocytes in the skin,
a known cutaneous reaction to drugs that induce a strong immune response [69]. We hypothesize
that, because respiration occurs mostly through the skin in amphibians, this reduction of the cornified
layer of the epidermis might facilitate the oxygen exchange needed for the mitochondrial processes
that are also upregulated in D. tinctorius. However, as a trade-off, it might also make frogs more
vulnerable to infections, water loss, and UV radiation. This downregulation of keratins upon alkaloid
consumption is further intriguing because two of the keratins differentially expressed in D. tinctorius,
KRT17 and KRT19, have recently been hypothesized to relate to the diversity of coloration patterns in
D. auratus [70]. This points to the intriguing possibility of a link between the two main traits of poison
frog aposematism, coloration and alkaloid-based toxicity or unpalatability, which remains to be tested
in future feeding experiments.
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